Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
4.240
-0.040 (-0.93%)
At close: May 22, 2026, 4:00 PM EDT
4.290
+0.050 (1.18%)
After-hours: May 22, 2026, 7:30 PM EDT

Precigen Revenue

Precigen had revenue of $23.25M in the quarter ending March 31, 2026, with 1,633.93% growth. This brings the company's revenue in the last twelve months to $31.60M, up 652.08% year-over-year. In the year 2025, Precigen had annual revenue of $9.68M with 146.73% growth.

Revenue (ttm)
$31.60M
Revenue Growth
+652.08%
P/S Ratio
47.84
Revenue / Employee
$197,469
Employees
160
Market Cap
1.51B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.68M5.76M146.73%
Dec 31, 20243.93M-2.30M-36.95%
Dec 31, 20236.23M-20.68M-76.87%
Dec 31, 202226.91M12.64M88.61%
Dec 31, 202114.27M-88.91M-86.17%
Dec 31, 2020103.18M12.46M13.73%
Dec 31, 201990.72M-60.46M-39.99%
Dec 31, 2018151.18M-68.29M-31.11%
Dec 31, 2017219.46M28.54M14.95%
Dec 31, 2016190.93M17.32M9.98%
Dec 31, 2015173.61M101.68M141.35%
Dec 31, 201471.93M71.13M8,891.25%
Dec 31, 2013800.00K-12.97M-94.19%
Dec 31, 201213.77M5.76M71.90%
Dec 31, 20118.01M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
Ardelyx427.68M
Immunocore Holdings412.81M
AbCellera Biologics79.21M
Vir Biotechnology65.50M
Immatics43.00M
uniQure18.09M
AtaiBeckley3.49M
Revenue Rankings